EVIDENCE-BASED INTEGRATIVE MEDICINE Quality Assessment of Clinical Research on Liver Cancer Treated by Intra-Arterial Infusion of Chinese Medicine

the studies was blinded. All of the articles didn't report the calculation of the sample size. Only six studies mentioned adverse reactions. All of the studies were of grade C according to the Cochrane Collaboration method. Six studies adverse reactions. All of the studies were of grade C according to the Cochrane Collaboration method. Six studies reported results of survival, and only two of these reported better effi cacy in the treatment groups. reported results of survival, and only two of these reported better effi cacy in the treatment groups. Conclusions: The quality of studies concerned intra-arterial infusion of CM in treating with PLC was poor and the exact effect of these quality of studies concerned intra-arterial infusion of CM in treating with PLC was poor and the exact effect of these medicines still need evaluation. Well designed RCTs with large sample sizes, adequate follow-up data and reliable medicines still need evaluation. Well designed RCTs with large sample sizes, adequate follow-up data and reliable methods of assessment are needed to better appraise the real effect of CMs in the treatment of PLC patients. methods of assessment are needed to better appraise the real effect of CMs in the treatment of PLC patients. KEYWORDS primary liver cancer, Chinese medicine, intra-arterial infusion, quality assessment primary liver cancer, Chinese medicine, intra-arterial infusion, quality assessment